APM: Aptorum Short-Term Debt to Equity

Corporate company logo of Aptorum Group Limited (APM)

Aptorum Group Limited (APM) is currently optimizing its portfolio of drugs targeting infections and rare pathologies while awaiting a strategic partnership. The business relies on identifying Asian biotech startups for their subsequent launch into the global market. This price chart featuring the 0.15 indicator reflects the asset's dynamics as the Hong Kong-based management seeks to validate its experience in conducting US clinical trials.

Aptorum Group Limited - APM Short-Term Debt to Equity Ratio (period 07/04/2022 - 07/20/2026)

Analytical breakdowns for Aptorum (APM)

- price and consensus price forecast:
Stock Price Aptorum Group Limited|APM - Analyst Consensus Forecast
- market capitalization data:
Market Value Aptorum Group Ltd|APM - Value Adjusted for Debt and Cash
- book capitalization data:
Net Assets per Single Share Aptorum Group|APM - Company Net Assets|Market Capitalization to Book Value Ratio aptorumgroup.com|APM - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio Aptorum Group Limited|APM - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Aptorum Group Limited|APM - Company Cumulative Debt|Debt to Book Value Aptorum Group Ltd|APM - Amount of Long-Term Liabilities|Company Short-Term Debts Aptorum Group
Fundamental company analysis:APM, Aptorum Group
Manufactured product of Aptorum Group Limited

For the biotechnology company Aptorum Group Limited (APM), which invests in laboratory greening and ESG filtration, the ratio of short-term borrowing to equity reflects the balance between operational flexibility and debt load. This metric compares liabilities maturing within one year against equity, allowing investors to assess liquidity risk and the efficiency of working capital management in sustaining the pace of technological growth.

Analysis of competing companies

Short-Term Debt to Capital HLN|Short-Term Debt to Capital KVUE (Kenvue Health)|Short-Term Debt to Equity Verona Pharma plc|jyongbio.com - Ratio of Short-Term Indebtedness to Capital|LGND: Short-Term Debt to Equity|AMRX - Short-Term Debt to Equity Ratio|PRGO: Short-Term Debt to Capital|Short-Term Debt to Capital Alvotech Biopharmaceuticals|LQDA - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital GLPG|ANI Pharmaceuticals, Inc. - Short-Term Debt to Equity|Current Liabilities to Capital MannKind Corp MNKD|Short-Term Debt to Equity Ratio Amphastar (AMPH)|Short-Term Loans to Capital Ratio Pacira Corp PCRX|Short-Term Debt to Capital ARS Pharmaceuticals (SPRY)|TBPH - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital AQST|SCPH (scPharmaceuticals) - Current Liabilities to Capital|TECX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Tonix Pharmaceuticals Holding|Short-Term Debt to Capital SXTC|Short-Term Debt to Capital EPRX (eupraxiapharma.com)|BioHarvest Sciences Inc. (BHST) - Short-Term Debt to Equity|EXOZ - Current Liabilities to Equity|Short-Term Debt to Equity Ratio Oramed Pharma ORMP|ENTX: Short-Term Loans to Capital Ratio|Short-Term Debt to Equity HYFT|ABVC (abvcpharma.com) - Current Liabilities to Capital|CPIX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Quantum BioPharma Ltd. (QNTM)|Short-Term Debt to Equity Ratio FGEN|Short-Term Debt to Capital TELO (Telomir Pharmaceuticals Corp)|Rani Therapeutics Holdings, Inc. - Short-Term Debt to Equity|SNYR - Short-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Rallybio Corp. (RLYB)|LEXX - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital PULM (Pulmatrix Corp)|PTHL (Pheton Holdings) - Short-Term Indebtedness to Equity|LYRA - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IBO|TNF Pharmaceuticals - Short-Term Debt to Equity|Current Liabilities to Capital cbdmd.com YCBD|Short-Term Debt to Equity Ratio PRFX (PainReform Limited)|Altamira Therapeutics Ltd - Short-Term Debt to Capital|Short-Term Debt to Equity Lipella Pharmaceuticals|optinose.com (OPTN) - Current Liabilities to Equity|Short-Term Debt to Equity Ratio Pieris Pharmaceuticals, Inc. PIRS|PROC (Procaps Group) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Petros|Short-Term Debt to Equity Qilian International Corp|SLRN (Acelyrin, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient TFFP (tffpharma.com)